Regeneron Announces New Investment in Manufacturing of its Industry-Leading Biologic Medicines
Provided By GlobeNewswire
Last update: Apr 22, 2025
New manufacturing and supply agreement with FUJIFILM Diosynth Biotechnologies in North Carolina will enable additional production of Regeneron’s biologic medicines and support high-paying jobs in the region
NASDAQ:REGN (4/25/2025, 3:27:21 PM)
600.71
+0.95 (+0.16%)
Find more stocks in the Stock Screener
REGN Latest News and Analysis
4 days ago - ChartmillDiscover which S&P500 stocks are making waves on Monday.Curious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session.
16 days ago - ChartmillThese S&P500 stocks are gapping in today's sessionLet's have a look at the S&P500 gap up and gap down stocks in today's session.
